Canaccord Genuity Maintains Buy on Doximity, Lowers Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Richard Close has maintained a 'Buy' rating on Doximity (NYSE:DOCS) but lowered the price target from $40 to $33.
September 05, 2023 | 4:29 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Canaccord Genuity has maintained a 'Buy' rating on Doximity but lowered the price target from $40 to $33.
The news is directly related to Doximity (DOCS). While the 'Buy' rating is maintained, the lowering of the price target might indicate a potential downside risk. However, the impact on the stock price is uncertain in the short term as it depends on how investors interpret this information.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100